PODD Insulet Corporation
Healthcare$154.87+0.00%OpenMarket Cap: $10.73B
As of 2026-05-26
Valuation
P/E (TTM)
57.68
PEG
—
P/B
8.32
P/S
3.70
EV/EBITDA
19.94
DCF Value
$-31.84
FCF Yield
3.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
71.0%
Operating Margin
17.5%
Net Margin
10.4%
ROE
21.4%
ROA
10.1%
ROIC
16.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $761.7M | 69.5% | $122.1M | $91.1M | $— | — |
| Q4 null | $783.8M | 72.5% | $146.3M | $101.6M | $— | — |
| FY null | $2.71B | 71.6% | $473.8M | $247.1M | $— | — |
| Q3 null | $706.3M | 72.2% | $117.7M | $87.6M | $— | — |
| Q2 null | $649.1M | 69.7% | $121.1M | $22.5M | $— | — |
| Q1 null | $569.0M | 71.9% | $88.8M | $35.4M | $— | — |
| Q4 null | $597.5M | 72.1% | $109.3M | $100.7M | $— | — |
| FY null | $2.07B | 69.8% | $308.9M | $418.3M | $— | — |
| Q3 null | $543.9M | 69.3% | $88.1M | $77.5M | $— | — |
| Q2 null | $488.5M | 67.7% | $54.5M | $188.6M | $— | — |
| Q1 null | $441.7M | 69.5% | $56.9M | $51.5M | $— | — |
| Q4 2023 | $509.8M | 70.9% | $106.4M | $103.3M | $1.48 | — |